Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 1
1997 1
1998 2
1999 5
2000 7
2001 3
2002 1
2003 5
2004 3
2005 5
2007 2
2008 3
2009 6
2010 7
2011 5
2012 3
2013 11
2014 3
2015 8
2016 6
2017 7
2018 6
2019 8
2020 9
2021 7
2022 3
2023 3
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Biodegradable-polymer versus durable-polymer drug-eluting stents in left main percutaneous coronary intervention: final results of the randomised IDEAL-LM trial.
Griffioen AM, van Geuns RM, McEntegart MB, Merkulov E, Krestyaninov O, Kretov E, Lesiak M, O'Kane P, Hanratty CG, Bressollette E, Silvestri M, Wlodarczak A, Barragan P, Anderson R, Protopopov A, Peace A, Menown I, Rocchiccioli P, Onuma Y, Oldroyd KG. Griffioen AM, et al. EuroIntervention. 2025 Jun 2;21(11):e639-e641. doi: 10.4244/EIJ-D-24-00918. EuroIntervention. 2025. PMID: 40464672 No abstract available.
Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry.
Cortese B, Testa L, Heang TM, Ielasi A, Bossi I, Latini RA, Lee CY, Perez IS, Milazzo D, Caiazzo G, Tomai F, Benincasa S, Nuruddin AA, Stefanini G, Buccheri D, Seresini G, Singh R, Karavolias G, Cacucci M, Sciahbasi A, Ocaranza R, Menown IBA, Torres A, Sengottvelu G, Zanetti A, Pesenti N, Colombo A; EASTBOURNE Investigators. Cortese B, et al. JACC Cardiovasc Interv. 2023 Jul 24;16(14):1794-1803. doi: 10.1016/j.jcin.2023.05.005. JACC Cardiovasc Interv. 2023. PMID: 37495352 Free article.
Sex-Specific Clinical Outcomes After Treatment of Left Main Coronary Artery Disease. A NOBLE Substudy.
McEntegart MB, Holm NR, Lindsay MM, Oldroyd KG, Mäkikallio T, Hildick-Smith D, Erglis A, Kellerth T, Davidavicius G, Menown IBA, Mogensen LJH, Nielsen PH, Steigen TK, Endresen PC, Spence MS, Graham ANJ, Stradins P, Anttila V, Thuesen L, Christiansen EH; NOBLE Study Investigators. McEntegart MB, et al. J Soc Cardiovasc Angiogr Interv. 2022 May 30;1(4):100338. doi: 10.1016/j.jscai.2022.100338. eCollection 2022 Jul-Aug. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39131931 Free PMC article.
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.
van Geuns RJ, Chun-Chin C, McEntegart MB, Merkulov E, Kretov E, Lesiak M, O'Kane P, Hanratty CG, Bressollette E, Silvestri M, Wlodarczak A, Barragan P, Anderson R, Protopopov A, Peace A, Menown I, Rocchiccioli P, Onuma Y, Oldroyd KG. van Geuns RJ, et al. EuroIntervention. 2022 Apr 22;17(18):1467-1476. doi: 10.4244/EIJ-D-21-00514. EuroIntervention. 2022. PMID: 35285803 Free PMC article. Clinical Trial.
Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes.
Menown IBA, Mamas MA, Cotton JM, Hildick-Smith D, Eberli FR, Leibundgut G, Tresukosol D, Macaya C, Copt S, Slama SS, Oldroyd KG. Menown IBA, et al. J Interv Cardiol. 2021 Apr 1;2021:6654515. doi: 10.1155/2021/6654515. eCollection 2021. J Interv Cardiol. 2021. PMID: 33880087 Free PMC article.
Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis: A NOBLE Trial Substudy.
Steigen T, Holm NR, Myrmel T, Endresen PC, Trovik T, Mäkikallio T, Lindsay M, Spence MS, Erglis A, Menown IBA, Kumsars I, Kellerth T, Davidavičius G, Linder R, Anttila V, Juul Hune Mogensen L, Hostrup Nielsen P, Graham ANJ, Hildick-Smith D, Thuesen L, Christiansen EH; NOBLE Study Investigators. Steigen T, et al. Cardiology. 2021;146(4):409-418. doi: 10.1159/000515376. Epub 2021 Apr 13. Cardiology. 2021. PMID: 33849035
Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
Kerkmeijer LSM, Chandrasekhar J, Kalkman DN, Woudstra P, Menown IBA, Suryapranata H, den Heijer P, Iñiguez A, van 't Hof AWJ, Erglis A, Arkenbout KE, Muller P, Koch KT, Tijssen JG, Beijk MAM, de Winter RJ. Kerkmeijer LSM, et al. Catheter Cardiovasc Interv. 2021 Sep;98(3):503-510. doi: 10.1002/ccd.29305. Epub 2020 Oct 8. Catheter Cardiovasc Interv. 2021. PMID: 33029937 Free PMC article.
Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy.
Ladwiniec A, Walsh SJ, Holm NR, Hanratty CG, Mäkikallio T, Kellerth T, Hildick-Smith D, Mogensen LJH, Hartikainen J, Menown IBA, Erglis A, Eriksen E, Spence MS, Thuesen L, Christiansen EH. Ladwiniec A, et al. EuroIntervention. 2020 Jun 25;16(3):201-209. doi: 10.4244/EIJ-D-19-01003. EuroIntervention. 2020. PMID: 32122821 Free article. Clinical Trial.
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
Holm NR, Mäkikallio T, Lindsay MM, Spence MS, Erglis A, Menown IBA, Trovik T, Kellerth T, Kalinauskas G, Mogensen LJH, Nielsen PH, Niemelä M, Lassen JF, Oldroyd K, Berg G, Stradins P, Walsh SJ, Graham ANJ, Endresen PC, Fröbert O, Trivedi U, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH; NOBLE investigators. Holm NR, et al. Lancet. 2020 Jan 18;395(10219):191-199. doi: 10.1016/S0140-6736(19)32972-1. Epub 2019 Dec 23. Lancet. 2020. PMID: 31879028 Clinical Trial.
Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry.
Kerkmeijer LS, Kalkman DN, Woudstra P, Menown IBA, Suryapranata H, den Heijer P, Iñiguez A, Van't Hof AWJ, Erglis A, Arkenbout KE, Muller P, Koch KT, Tijssen JG, Beijk MAM, de Winter RJ. Kerkmeijer LS, et al. Cardiovasc Revasc Med. 2020 May;21(5):567-570. doi: 10.1016/j.carrev.2019.09.015. Epub 2019 Oct 25. Cardiovasc Revasc Med. 2020. PMID: 31662276
1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.
de Winter RJ, Chandrasekhar J, Kalkman DN, Aquino MB, Woudstra P, Beijk MA, Sartori S, Baber U, Tijssen JG, Koch KT, Dangas GD, Colombo A, Mehran R; MASCOT; REMEDEE Registry Investigators. de Winter RJ, et al. JACC Cardiovasc Interv. 2018 Oct 8;11(19):1969-1978. doi: 10.1016/j.jcin.2018.04.038. JACC Cardiovasc Interv. 2018. PMID: 30286855 Free article. Clinical Trial.
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, Trovik T, Eskola M, Romppanen H, Kellerth T, Ravkilde J, Jensen LO, Kalinauskas G, Linder RB, Pentikainen M, Hervold A, Banning A, Zaman A, Cotton J, Eriksen E, Margus S, Sørensen HT, Nielsen PH, Niemelä M, Kervinen K, Lassen JF, Maeng M, Oldroyd K, Berg G, Walsh SJ, Hanratty CG, Kumsars I, Stradins P, Steigen TK, Fröbert O, Graham AN, Endresen PC, Corbascio M, Kajander O, Trivedi U, Hartikainen J, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH; NOBLE study investigators. Mäkikallio T, et al. Lancet. 2016 Dec 3;388(10061):2743-2752. doi: 10.1016/S0140-6736(16)32052-9. Epub 2016 Oct 31. Lancet. 2016. PMID: 27810312 Clinical Trial.
2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.
Garot P, Morice MC, Tresukosol D, Pocock SJ, Meredith IT, Abizaid A, Carrié D, Naber C, Iñiguez A, Talwar S, Menown IBA, Christiansen EH, Gregson J, Copt S, Hovasse T, Lurz P, Maillard L, Krackhardt F, Ong P, Byrne J, Redwood S, Windhövel U, Greene S, Stoll HP, Urban P; LEADERS FREE Investigators. Garot P, et al. J Am Coll Cardiol. 2017 Jan 17;69(2):162-171. doi: 10.1016/j.jacc.2016.10.009. Epub 2016 Oct 30. J Am Coll Cardiol. 2017. PMID: 27806919 Free article. Clinical Trial.
One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent.
Kalkman DN, Woudstra P, den Heijer P, Menown IB, Erglis A, Suryapranata H, Arkenbout KE, Iñiguez A, van 't Hof AW, Muller P, Tijssen JG, de Winter RJ. Kalkman DN, et al. Int J Cardiol. 2017 Jan 1;226:60-64. doi: 10.1016/j.ijcard.2016.10.032. Epub 2016 Oct 17. Int J Cardiol. 2017. PMID: 27788391 Free article. Clinical Trial.
1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
Woudstra P, Kalkman DN, den Heijer P, Menown IB, Erglis A, Suryapranata H, Arkenbout KE, Iñiguez A, van 't Hof AW, Muller P, Tijssen JG, de Winter RJ. Woudstra P, et al. JACC Cardiovasc Interv. 2016 Jun 13;9(11):1127-34. doi: 10.1016/j.jcin.2016.02.052. Epub 2016 May 18. JACC Cardiovasc Interv. 2016. PMID: 27209254 Free article. Clinical Trial.
Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries.
Zhao M, Cooney MT, Klipstein-Grobusch K, Vaartjes I, De Bacquer D, De Sutter J, Reiner Ž, Prescott E, Faggiano P, Vanuzzo D, AlFaleh H, Menown IB, Gait D, Posogova N, Sheu WH, Zhao D, Zuo H, Grobbee DE, Graham IM. Zhao M, et al. Eur J Prev Cardiol. 2016 Jul;23(11):1202-10. doi: 10.1177/2047487316647827. Epub 2016 Apr 26. Eur J Prev Cardiol. 2016. PMID: 27118362
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.
Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC; LEADERS FREE Investigators. Urban P, et al. N Engl J Med. 2015 Nov 19;373(21):2038-47. doi: 10.1056/NEJMoa1503943. Epub 2015 Oct 14. N Engl J Med. 2015. PMID: 26466021 Free article. Clinical Trial.
A Review of the Key Clinical Trials of 2014.
McKavanagh P, McCune C, Menown IB. McKavanagh P, et al. Cardiol Ther. 2015 Jun;4(1):5-23. doi: 10.1007/s40119-015-0036-0. Epub 2015 Mar 27. Cardiol Ther. 2015. PMID: 25814425 Free PMC article.
Editors' Picks for 2014 and a Look into the Future.
Giugliano RP, Zeymer U, Menown I. Giugliano RP, et al. Cardiol Ther. 2015 Jun;4(1):1-3. doi: 10.1007/s40119-015-0038-y. Epub 2015 Mar 13. Cardiol Ther. 2015. PMID: 25766962 Free PMC article. No abstract available.
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE).
Tamburino C, Capodanno D, Erglis A, Menown IB, Horváth IG, Moreno R, Gilbert TJ, Crowley JJ, Calabria P, Allocco DJ, Dawkins KD. Tamburino C, et al. EuroIntervention. 2015 Mar;10(11):1261-6. doi: 10.4244/EIJY15M01_01. EuroIntervention. 2015. PMID: 25572023 Free article.
ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.
Sinnaeve PR, Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Lambert Y, Danays T, Soulat L, Halvorsen S, Ortiz FR, Vandenberghe K, Regelin A, Bluhmki E, Bogaerts K, Van de Werf F; STREAM investigators. Sinnaeve PR, et al. Circulation. 2014 Sep 30;130(14):1139-45. doi: 10.1161/CIRCULATIONAHA.114.009570. Epub 2014 Aug 26. Circulation. 2014. PMID: 25161043 Clinical Trial.
Advances in clinical cardiology.
McNeice AH, McAleavey NM, Menown IB. McNeice AH, et al. Adv Ther. 2014 Aug;31(8):837-60. doi: 10.1007/s12325-014-0141-9. Epub 2014 Jul 30. Adv Ther. 2014. PMID: 25074280 Review.
2013: The year of renal denervation?
Menown IB. Menown IB. Adv Ther. 2013 Dec;30(12):1038-40. doi: 10.1007/s12325-013-0082-8. Epub 2013 Dec 13. Adv Ther. 2013. PMID: 24338708 Free PMC article. No abstract available.
A prospective intravascular ultrasound investigation of the necessity for and efficacy of postdilation beyond nominal diameter of 3 current generation DES platforms for the percutaneous treatment of the left main coronary artery.
Shand JA, Sharma D, Hanratty C, McClelland A, Menown IB, Spence MS, Richardson G, Herity NA, Walsh SJ. Shand JA, et al. Catheter Cardiovasc Interv. 2014 Sep 1;84(3):351-8. doi: 10.1002/ccd.25265. Epub 2013 Nov 9. Catheter Cardiovasc Interv. 2014. PMID: 24167078
Key advances in clinical cardiology.
Connolly M, Menown IB. Connolly M, et al. Adv Ther. 2013 Apr;30(4):369-86. doi: 10.1007/s12325-013-0024-5. Epub 2013 Apr 9. Adv Ther. 2013. PMID: 23579862 Review.
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction.
Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F; STREAM Investigative Team. Armstrong PW, et al. N Engl J Med. 2013 Apr 11;368(15):1379-87. doi: 10.1056/NEJMoa1301092. Epub 2013 Mar 10. N Engl J Med. 2013. PMID: 23473396 Free article. Clinical Trial.
A timely diagnosis of myocardial infarction.
Shand JA, Menown IB, McEneaney DJ. Shand JA, et al. Biomark Med. 2010 Jun;4(3):385-93. doi: 10.2217/bmm.10.16. Biomark Med. 2010. PMID: 20550472 Review.
Recent advances in cardiology.
Menown IA, Shand JA. Menown IA, et al. Future Cardiol. 2010 Jan;6(1):11-7. doi: 10.2217/fca.09.59. Future Cardiol. 2010. PMID: 20014984 Review.
Remodelling of coronary arteries.
Pal N, Menown I. Pal N, et al. BMJ Case Rep. 2009;2009:bcr04.2009.1762. doi: 10.1136/bcr.04.2009.1762. Epub 2009 Sep 7. BMJ Case Rep. 2009. PMID: 21897835 Free PMC article. No abstract available.
Aborted infarction: the ultimate myocardial salvage.
Dowdy L, Wagner GS, Birnbaum Y, Clemmensen P, Fu Y, Maynard C, Menown I, Sejersten M, Young D, Johanson P, Barbagelata A. Dowdy L, et al. Am Heart J. 2004 Mar;147(3):390-4. doi: 10.1016/j.ahj.2003.10.008. Am Heart J. 2004. PMID: 14999184 No abstract available.
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators.
Antman EM, Gibson CM, de Lemos JA, Giugliano RP, McCabe CH, Coussement P, Menown I, Nienaber CA, Rehders TC, Frey MJ, Van der Wieken R, Andresen D, Scherer J, Anderson K, Van de Werf F, Braunwald E. Antman EM, et al. Eur Heart J. 2000 Dec;21(23):1944-53. doi: 10.1053/euhj.2000.2243. Eur Heart J. 2000. PMID: 11071800 Clinical Trial.
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.
Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, Vahanian A, Adgey AA, Menown I, Rupprecht HJ, Van der Wieken R, Ducas J, Scherer J, Anderson K, Van de Werf F, Braunwald E. Antman EM, et al. Circulation. 1999 Jun 1;99(21):2720-32. doi: 10.1161/01.cir.99.21.2720. Circulation. 1999. PMID: 10351964 Clinical Trial.
Retro-pharyngeal liposarcoma.
Menown IB, Liew SH, Napier SS, Primrose WJ. Menown IB, et al. J Laryngol Otol. 1992 May;106(5):469-71. doi: 10.1017/s0022215100119875. J Laryngol Otol. 1992. PMID: 1613385